A patient is diagnosed with postpartum hemorrhage only after there has been a loss of at least 500 ml of blood after a vaginal delivery, and at least 1,000 ml in the case of cesarean delivery, both within a certain time frame. If the mother has lost the specified amount of blood within 24 hours of delivery, it is known as primary PPH, while it is classified as secondary PPH if she bleeds after 24 hours of delivery.
This 98 page report gives readers a comprehensive overview of the Postpartum Hemorrhage (PPH) Treatment Devices Market. Browse through 9 data tables and 30 figures to unlock the hidden opportunities in this market: http://www.transparencymarketresearch.com/postpartum-hemorrhage-treatment-devices-market.html
According to the report, the global postpartum hemorrhage treatment devices market is primarily being driven by the rising cases of PPH across the world. This market is also benefitting from the increased investment efforts taken up by multiple governments, along with the steadily growing education programs and awareness towards the complications caused by PPH and the various treatment solutions available.
The global postpartum hemorrhage treatment devices market is currently, however, still facing the major hindrance of a very low awareness rate. This applies especially to developing economies where the market is stifled by a high rate of social rejection rates related to any modern and unconventional treatments and preventive devices.
The report divides the global postpartum hemorrhage treatment devices market on the basis of products into uterine balloon tamponade, Uniject prefilled infection systems, and non-pneumatic anti-shock garments. The segment of uterine balloon tamponades led the market in 2014 owing to low cost and a higher availability rate. The segment of Uniject prefilled injection systems is exhibiting the fastest growth rate for the report’s forecast period.
Geographically, the global postpartum hemorrhage treatment devices market was led by North America in 2014 owing to several factors. These include the rising number of PPH cases and related maternal mortality rate along with the higher availability of modern and advanced healthcare. At the same time, Asia Pacific is expected to report the fastest growth rate due to a rapidly increasing awareness rate and major improvements in healthcare infrastructure. Another factor to consider, especially for developing economies such as Hong Kong, China, and India, is the high rate of anemia among women. More than 60% of the average population of women is suffering from anemia, which is one of the leading causes of PPH.
Get accurate market forecast and analysis on the Postpartum Hemorrhage (PPH) Treatment Devices Market. Request a sample to stay abreast on the key trends impacting this market: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=6164
The key players in the global postpartum hemorrhage treatment devices market are discussed in detail within the report. These include Zoex, Utah Medical Products, Inc., Teleflex Incorporated, Program for Appropriate Technology in Health (PATH), C. R. Bard, Inc., Cook Medical, Inc., Bactiguard AB, and 3rd Stone Design, Inc.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA – Canada Toll Free: 866-552-3453